Every material Form 8-K Jackson Acquisition Co II filed with the SEC in 2024, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Jackson Acquisition Company II, a blank check company focused on healthcare, closed its initial public offering on December 11, 2024, including the full exercise of the underwriter's over-allotment option. The company placed $232.3 million in a trust account, and it has 24 months from the IPO closing to complete a business combination or redeem public shares.
Sold 23,000,000 units at $10.00 each for gross proceeds of $230 million, including 3,000,000 over-allotment units.
Sold 840,000 private placement units for $8.4 million to RJ Healthcare SPAC II, LLC and Roth Capital Partners, LLC.
Placed $232.3 million in a trust account with Continental Stock Transfer & Trust Company, or $10.10 per Unit.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Jackson Acquisition Co II filing is on SEC EDGAR ↗. 8-K briefs of other companies →